You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
2 April 2025 - Diagnostic information services provider Quest Diagnostics (NYSE: DGX) has introduced a human papillomavirus (HPV) self-collection solution for cervical cancer screening, allowing physicians in the United States to offer patients the o...
2 April 2025 - UK-based biopharmaceutical company Ananda Pharma plc (AQSE: ANA) announced on Wednesday that it has received approval from the Alfred Hospital Human Research Ethics Committee (HREC) in Australia for its Phase 1 pharmacokinetic study of...
2 April 2025 - Nasal photodisinfection system provider Ondine Biomedical Inc (LON: OBI) on Wednesday announced successful results from the first NHS deployment of its Steriwave nasal decolonisation technology at Mid Yorkshire Teaching NHS Trust (Mid ...
2 April 2025 - AKAGERA Medicines Inc, a biotech company developing novel lipid nanoparticle formulations of antibacterial drugs and mRNA vaccines to treat tuberculosis, avian flu, RSV and other infectious diseases, announced on Tuesday that it has co...
1 April 2025 - Healthcare company Organon (NYSE:OGN) announced on Tuesday that it has acquired the US regulatory and commercial rights to TOFIDENCE, a biosimilar to ACTEMRA, from biotechnology company Biogen Inc (Nasdaq:BIIB).TOFIDENCE, launched in M...
1 April 2025 - Swedish orthobiologics company Bonesupport Holding AB (STO:BONEX) said on Tuesday that it has submitted a market authorisation application to the US Food and Drug Administration (FDA) for CERAMENT V (vancomycin), its antibiotic-eluting...
1 April 2025 - Precision medicine software company GenomOncology on Monday announced a collaboration with Chronetyx Laboratories, a provider of advanced diagnostic solutions, to accelerate cancer care through comprehensive genomic profiling.The partn...